Hari K. Kadam
Hari K. Kadam publishes mostly in Organic Chemistry, Molecular Biology and Materials Chemistry, on topics such as Synthesis and pharmacology of benzodiazepine derivatives, Cancer therapeutics and mechanisms and Synthesis and bioactivity of alkaloids.
- World rank
- #4,557,953 of 7,710,434 ranked researchers
- Rank in India
- #117,710 of 280,097
- Works
- 34
- Citations
- 698
- Citations per work
- 20.5
What does Hari K. Kadam research?
Hari K. Kadam's work is mostly in Chemistry (48%), Biochemistry, Genetics and Molecular Biology (18%), Materials Science (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Physical Sciences2060.2%
- Chemistry1648.4%
- Materials Science25.4%
- Chemical Engineering13.2%
- Engineering13.2%
- Life Sciences618.3%
- Everything else617.2%
- Health Sciences14.3%
- Medicine14.3%
- 1Organic Chemistry48% of their works
- 2Molecular Biology18% of their works
- 3Materials Chemistry5% of their works
- 4Pharmacology4% of their works
- 5Biomedical Engineering3% of their works
- 6Catalysis3% of their works
Research topics
- Synthesis and pharmacology of benzodiazepine derivatives
- Cancer therapeutics and mechanisms
- Synthesis and bioactivity of alkaloids
- Multicomponent Synthesis of Heterocycles
- Synthesis and biological activity
- Synthesis and Reactions of Organic Compounds
- Nanomaterials for catalytic reactions
- Synthesis and Characterization of Pyrroles
Which keywords describe Hari K. Kadam's research?
The keywords of their largest research topics: Synthesis, Asymmetric Synthesis, Cytotoxicity, Anticancer Agents, Catalysis, Multicomponent Reactions, DNA-Interactive Agents and Pyrrolobenzodiazepines.
- Tubulin Inhibitors
- Oxazolones
- Medicinal Chemistry
- Imidazoles
- Topoisomerases
- Heterocyclic Synthesis
- Green Chemistry
- Chemoselective
- Pyrrolobenzodiazepines
- Multicomponent Reactions
- Anticancer Agents
- Asymmetric Synthesis
- Synthesis
- Cytotoxicity
- Catalysis
- DNA-Interactive Agents
- Beta-Carboline Alkaloids
- DNA
- Heterocyclic Compounds
- Pharmacological Functions
- Catalytic Reduction
- Marine Alkaloids
- Nitro Compounds
- Pyrrole
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 24 words, with their numbers
- Synthesis194 topics
- Asymmetric Synthesis132 topics
- Cytotoxicity132 topics
- Anticancer Agents123 topics
- Catalysis92 topics
- Multicomponent Reactions92 topics
- DNA-Interactive Agents71 topic
- Pyrrolobenzodiazepines71 topic
- Beta-Carboline Alkaloids61 topic
- Chemoselective62 topics
- DNA61 topic
- Green Chemistry61 topic
- Heterocyclic Compounds62 topics
- Heterocyclic Synthesis61 topic
- Pharmacological Functions61 topic
- Topoisomerases61 topic
- Catalytic Reduction31 topic
- Imidazoles31 topic
- Marine Alkaloids31 topic
- Medicinal Chemistry31 topic
- Nitro Compounds31 topic
- Oxazolones31 topic
- Pyrrole31 topic
- Tubulin Inhibitors31 topic
Where does Hari K. Kadam work?
Hari K. Kadam's main affiliation in the publication record is Goa University, India.
How many publications and citations does Hari K. Kadam have?
OpenAlex counts 34 works and 698 citations for Hari K. Kadam, an h-index of 11, ranking #4,557,953 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Hari K. Kadam. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.